Pharmaust Limited (ECQ0) Stock Statistics & Valuation Metrics
Total Valuation
Pharmaust Limited has a market cap or net worth of EUR 42.71M. The enterprise value is EUR 36.12M.
- Market Cap
- EUR 42.71M
- Enterprise Value
- EUR 36.12M
Share Statistics
Pharmaust Limited has 791,652,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 791,652,340
- Owned by Insiders
- 3.93%
- Owned by Institutions
- ―
Financial Efficiency
Pharmaust Limited’s return on equity (ROE) is -0.84 and return on invested capital (ROIC) is -68.44%.
- Return on Equity (ROE)
- -0.84
- Return on Assets (ROA)
- -0.45
- Return on Invested Capital (ROIC)
- -68.44%
- Return on Capital Employed (ROCE)
- -2.18
- Revenue Per Employee
- 488.49K
- Profits Per Employee
- -297.86K
- Employee Count
- 36
- Asset Turnover
- 0.74
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Pharmaust Limited is -4.91. Pharmaust Limited’s PEG ratio is -0.08.
- PE Ratio
- -4.91
- PS Ratio
- 0.00
- PB Ratio
- 5.13
- Price to FCF
- -4.51
- Price to Operating Cash Flow
- -4.33
- PEG Ratio
- -0.08
Income Statement
In the last 12 months, Pharmaust Limited had revenue of 17.59M and earned -10.72M in profits. Earnings per share was -0.02.
- Revenue
- 17.59M
- Gross Profit
- 17.59M
- Operating Income
- -27.76M
- Pretax Income
- -27.08M
- Net Income
- -10.72M
- EBITDA
- -27.75M
- Earnings Per Share (EPS)
- -0.02
Cash Flow
In the last 12 months, operating cash flow was -15.07M and capital expenditures -8,223, giving a free cash flow of -15.08M billion.
- Operating Cash Flow
- -15.07M
- Free Cash Flow
- -15.08M
- Free Cash Flow per Share
- -0.02
Dividends & Yields
Pharmaust Limited pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -22.15%
- Earnings Yield
- -16.44%
Stock Price Statistics
- Beta
- 0.41
- 52-Week Price Change
- -34.29%
- 50-Day Moving Average
- 0.04
- 200-Day Moving Average
- 0.04
- Relative Strength Index (RSI)
- 61.40
- Average Volume (3m)
- 13.00K
Important Dates
Pharmaust Limited upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Mar 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Pharmaust Limited as a current ratio of 2.16, with Debt / Equity ratio of 26.02%
- Current Ratio
- 2.16
- Quick Ratio
- 2.16
- Debt to Market Cap
- 0.09
- Net Debt to EBITDA
- 0.34
- Interest Coverage Ratio
- -37.65
Taxes
In the past 12 months, Pharmaust Limited has paid -16.36M in taxes.
- Income Tax
- -16.36M
- Effective Tax Rate
- 0.60
Enterprise Valuation
Pharmaust Limited EV to EBITDA ratio is -2.12, with an EV/FCF ratio of -3.89.
- EV to Sales
- 0.00
- EV to EBITDA
- -2.12
- EV to Free Cash Flow
- -3.89
- EV to Operating Cash Flow
- -3.89
Balance Sheet
Pharmaust Limited has EUR 12.71M in cash and marketable securities with EUR 3.31M in debt, giving a net cash position of EUR 9.40M billion.
- Cash & Marketable Securities
- EUR 12.71M
- Total Debt
- EUR 3.31M
- Net Cash
- EUR 9.40M
- Net Cash Per Share
- EUR 0.01
- Tangible Book Value Per Share
- EUR 0.02
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Pharmaust Limited is EUR 0.13, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 0.13
- Price Target Upside
- 172.73% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 48.74%
Scores
- Smart Score
- 7
- AI Score
- ―